​

 

1992:

1.            Bernton EW, Bryant HU, Decoster MA, Orenstein JM, Ribas JL, Meltzer MS, et al. No direct neurotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytes. AIDS Res Hum Retroviruses. 1992;8(4):495-503.

​

2.          DeCoster MA, Koenig ML, Hunter JC, Tortella FC. Calcium dynamics in neurons treated with toxic and non-toxic concentrations of glutamate. Neuroreport. 1992;3(9):773-6.

​

​

1994:

3.          DeCoster MA, Conover JR, Hunter JC, Tortella FC. The neuroprotective kappa-opioid CI-977 alters glutamate-induced calcium signaling in vitro. Neuroreport. 1994;5(17):2305-10.

​

4.          DeCoster MA, Yourick DL. Development of glutamate-stimulated phosphatidylinositol metabolism in primary neuronal and astrocyte cultures. Int J Dev Neurosci. 1994;12(3):227-33.

​

5.          Koenig ML, Rothbard PM, DeCoster MA, Meyerhoff JL. N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro. Neuroreport. 1994;5(9):1063-8.

 

6.          Wesche DL, DeCoster MA, Tortella FC, Brewer TG. Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother. 1994;38(8):1813-

​

​

1995:

7.          DeCoster MA, Klette KL, Knight ES, Tortella FC. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 1995;671(1):45-53.

​

8.            Clapp LE, Klette KL, DeCoster MA, Bernton E, Petras JM, Dave JR, et al. Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats. Brain Res. 1995;693(1-2):101-11.

​

9.          DeCoster MA. Calcium dynamics in the central nervous system. Adv Neuroimmunol. 1995;5(3):233-9.

​

10.          Klette KL, DeCoster MA, Moreton JE, Tortella FC. Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons. Brain Res. 1995;704(1):31-41.

​

11.          Tortella FC, Klette KL, DeCoster MA, Davis BJ, Newman AH. Dextromethorphan analogs are neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons. Neurosci Lett. 1995;198(2):79-82.

​

​

1996:

12.          Kolko M, DeCoster MA, de Turco EB, Bazan NG. Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem. 1996;271(51):32722-8.

​

13.          Potegal M, Hebert M, DeCoster M, Meyerhoff JL. Brief, high-frequency stimulation of the corticomedial amygdala induces a delayed and prolonged increase of aggressiveness in male Syrian golden hamsters. Behav Neurosci. 1996;110(2):401-12.

​

​

1997:

14.            Bazan HE, Tao Y, DeCoster MA, Bazan NG. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci. 1997;38(12):2492-501.

 

15.            Bazan NG, Gordon WC, Marcheselli VL, Lukiw WJ, Duhault J, Koenig-Berard E, et al. Experimental models and their use in studies of diabetic retinal microangiopathy. Therapie. 1997;52(5):447-51.

​

16.          Klette KL, Lin Y, Clapp LE, DeCoster MA, Moreton JE, Tortella FC. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res. 1997;756(1-2):231-40.

​

​

1998:

17.          DeCoster MA, Mukherjee PK, Davis RJ, Bazan NG. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. J Neurosci Res. 1998;53(3):297-303.

​

18.          Ogden F, DeCoster MA, Bazan NG. Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis. J Neurosci Res. 1998;53(6):677-84.

 

​

1999:

19.            Bennink R, Van Poppel H, Billen J, Decoster M, Baert L, Mortelmans L, et al. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer. Anticancer Res. 1999;19(4A):2609-13.

 

20.          Serou MJ, DeCoster MA, Bazan NG. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res. 1999;58(4):593-8.

​

​

2001:

21.          Jeanclos EM, Lin L, Treuil MW, Rao J, DeCoster MA, Anand R. The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunits. Evidence for a dynamic role in subunit stabilization. J Biol Chem. 2001;276(30):28281-90.

​

​

2002:

22.          DeCoster MA, Lambeau G, Lazdunski M, Bazan NG. Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J Neurosci Res. 2002;67(5):634-45.

​

23.            Decoster M, Bigot JC, Carre JL, Morin JF, Mahe JL, Tanquerel T, et al. [Epidemiologic study of urinary calculi in Western France]. Presse Med. 2002;31(3):113-8.

​

24.          Rodriguez De Turco EB, Jackson FR, DeCoster MA, Kolko M, Bazan NG. Glutamate signaling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res. 2002;68(5):558-67.

​

​

2003:

25.          DeCoster MA. Group III secreted phospholipase A2 causes apoptosis in rat primary cortical neuronal cultures. Brain Res. 2003;988(1-2):20-8.

​

​

2004:

26.            Daniel B, DeCoster MA. Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res Brain Res Protoc. 2004;13(3):144-50.

​

27.          Mohammed JS, DeCoster MA, McShane MJ. Micropatterning of nanoengineered surfaces to study neuronal cell attachment in vitro. Biomacromolecules. 2004;5(5):1745-55.

​

28.          Shaikh-Mohammed J, DeCoster MA, McShane MJ. Cell adhesion testing using novel testbeds containing micropatterns of complex nanoengineered multilayer films. Conf Proc IEEE Eng Med Biol Soc. 2004;4:2671-4.

 

​

2005:

29.            Bertrams C, DeCoster ML, Gooche DG, Englehart M, Martucci JB, Richards ML. Managing medical necessity denials. Healthc Financ Manage. 2005;59(8):95-100.

​

30.          Wang G, Daniel BM, DeCoster MA. Role of nitric oxide in regulating secreted phospholipase A2 release from astrocytes. Neuroreport. 2005;16(12):1345-50.

​

​

2011:

31.          Khaliq A, Jenkins F, DeCoster M, Dai W. A new 3D mass diffusion-reaction model in the neuromuscular junction. J Comput Neurosci. 2011;30(3):729-45.

 

​

2014:

32.          Parekh G, Pattekari P, Joshi C, Shutava T, DeCoster M, Levchenko T, et al. Layer-by-layer nanoencapsulation of camptothecin with improved activity. Int J Pharm. 2014;465(1-2):218-27.

 

 

2015:
33.            Cotton Kelly K, Wasserman JR, Deodhar S, Huckaby J, DeCoster MA. Generation of Scalable, Metallic High-Aspect-Ratio Nanocomposites in a Biological Liquid Medium. J Vis Exp. 2015(101):e5

 

 

2017:
34.          Nestorova GG, Hasenstein K, Nguyen N, DeCoster MA, Crews ND. Lab-on-a-chip mRNA purification and reverse transcription via a solid-phase gene extraction technique. Lab Chip. 2017;17(6):1128

​

35.         Marthe KS, Norcross Z, Karan A, Karekar N, DeCoster MA. BIOCOMPATIBILITY OF NOVEL COPPER-CONTAINING BIOCOMPOSITES IN QUANTIFIABLE MODEL CELL SYSTEM. Journal of the Mississippi Academy of Sciences. 2017;60(2):193.

​

​

2022:

36.        DeCoster, Mark & Khasru, Tasneem & McMahen, Kelly & Uppu, Navya. Green Synthesis of Metal-Organic Biohybrid (Mob) Nanomaterials. Recent Progress in Materials. 2022; 04. 1-14.

​